24-02-2022 дата публикации
Номер: US20220054409A1
Принадлежит:
A rapidly-orodispersible dosage form comprising a porous, bound-powder matrix and one or more internal cavities is provided, as well as three-dimensional printing methods for making the same. Each internal cavity is configured to contain one or more payloads, particularly pharmaceutical medicaments, while isolating the payloads from the external environment outside of the dosage form. Each payload can be contained within its cavity in its native form without having to be combined with the bound-powder matrix or binding liquid. Dosage forms can disintegrate in water or saliva in less than two minutes, independently of the payload(s) or medicament(s) contained within. The dosage forms can be formed as unitary tablets, or as two-piece tablets comprising a container body and a lidding body that are secured together to isolate the one or more cavities and their payloads inside. 1. A rapidly-orodispersible dosage form comprising a porous , durable body comprising a bound-powder material , the body having one or more interior empty cavities , preferably wherein the bound-powder material comprises an interconnected porous matrix of at least one ingestible powder material and at least one ingestible binder material.2. The rapidly-orodispersible dosage form according to claim 1 , the interconnected porous matrix consists of adjacent particles of the at least one ingestible powder material that are connected and bonded together by the at least one ingestible binder material that can bind to the particles of the powder material and to other binder material.3. The dosage form according to claim 1 , wherein the ingestible powder material comprises one or more pharmaceutical excipients selected from the group consisting of: a binder claim 1 , a disintegration agent claim 1 , a dispersant claim 1 , a sweetener claim 1 , a glidant claim 1 , a flavoring agent claim 1 , a surfactant claim 1 , a humectant claim 1 , a preservative claim 1 , an antioxidant claim 1 , a solvent claim 1 , ...
Подробнее